Senate panel approves tighter oversight of compounding pharmacies, but bill is under fire

Washington Post. May 23, 2013. Public health and consumer advocacy groups are attacking Senate legislation designed to tighten oversight of specialized pharmacies such as the one at the center of this past fall’s deadly meningitis outbreak, saying it does not adequately address health risks. Continue reading

Angelina Jolie’s Decision

Huffington Post. 16 May 2013. Dr. Diana Zuckerman writes, “Let’s use Angelina Jolie’s announcement to have a frank discussion of the treatment choices for breast cancer and to encourage women to make decisions based on their own situations not on the choice of a celebrity, however admirable she is.” Continue reading

FDA advisors vote against two drugs for menopausal hot flashes

Reuters. March 5, 2013. Advisers to the Food and Drug Administration on Monday voted against approval of two drugs designed to reduce the frequency and severity of hot flashes associated with menopause. “The FDA’s advisors did a great job today of carefully considering the scientific evidence,” said Diana Zuckerman, president of the National Research Center for Women & Families. Continue reading

Antibiotics: When Science and Wishful Thinking Collide

Health Affairs blog. January 25, 2013. Antibiotic resistance is a major concern confronting our health care system, and there is tremendous pressure on the Food and Drug Administration (FDA) to “do something” about it. Unfortunately, the FDA is responding by approving drugs that are likely to do more harm than good. Continue reading